|
Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients
RECRUITINGN/ASponsored by Tianjin Medical University General Hospital
Actively Recruiting
PhaseN/A
SponsorTianjin Medical University General Hospital
Started2023-12-01
Est. completion2024-11-30
Eligibility
Age20 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06108830
Summary
To explore the effects of esketamine combined with remimazolam on postoperative sleep disturbance and anxiety in surgical patients undergoing gastroenteroscopies
Eligibility
Age: 20 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Age 20-65 years old; 2. ASA classification is grade I-III; 3. Elective surgery is proposed 4. BMI of 19-30 kg/m2; 5. Patients who agreed to enroll in this study voluntarily Exclusion Criteria: 1. Those who are known to be allergic to the drug ingredients in this study and their allergic constitution; 2. Allergic history of general anesthesia drugs, opioid drugs, non-steroidal drugs; 3. History of neurological diseases; History of chronic pain; Drug and alcohol addiction; A long history of opioid use; Opiates were given 48 hours before surgery; 4. ASA rating of IV or V; 5. Coronary heart disease, bronchial asthma, severe hypertension, severe blood system dysfunction, liver and kidney function, electrolyte abnormalities; 6. History of gastrointestinal disease (peptic ulcer, Crohn's disease, ulcerative colitis); 7. Respiratory insufficiency, respiratory failure; 8. Patients who refused to use intravenous PCA for analgesia; 9. Pregnant or lactating women; 10. BMI\<18 kg/m2 or BMI\>30kg/m2; 11. Poor compliance, unable to complete the experiment according to the study plan; 12. Participants who have participated in clinical trials of other drugs within the last 4 weeks; 13. Any circumstances deemed unsuitable for inclusion by the researcher for any reason.
Conditions2
AnxietySleep Disturbance
Interventions3
Related trials
- Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia — Second Affiliated Hospital of Wenzhou Medical University
- Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI) — China Medical University, China
- Effect of Low-dose EsketaMine on dElirium in High-risk Elderly Patients uNdergoing elecTive Surgery (ELEMENT) — Nanfang Hospital, Southern Medical University
- Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients — Women's Hospital School Of Medicine Zhejiang University
- Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's Disease — Beijing Tiantan Hospital
- Metabolic Profiling of Esketamine Treatment in Depressive Disorder — University of Zagreb
- Personalized DBS Targeting for Treating Depression — Second Affiliated Hospital, School of Medicine, Zhejiang University
- A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder — Janssen Research & Development, LLC
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorTianjin Medical University General Hospital
Started2023-12-01
Est. completion2024-11-30
Eligibility
Age20 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06108830